职称：客座教授
研究方向：分子医学 数字健康 开放式创新 生物技术 天然产物 科学传播 分子药理学
Email：atanas.atanasov@dhps.lbg.ac.at
Atanas Georgiev Atanasov 教授是全球知名的分⼦医学和数字健康领域的科学家，担任Current Research in Bi otechnology 杂志主编 ， 被评为推特 （Twitter）上全球⼗⼤健康科技影响⼒⼈物 。Atanas Georgiev Atanasov 教授致⼒于分⼦医学、数字健康 、天然产品、⽣物技术以及药物等领域开展了领先的研究 ，以更好地 理解健康和疾病的调控机制。在Nature Reviews Drug Discovery , Biotechnology Advances 等杂志发表 SCI 论 ⽂ 330 余篇 ，被引⽤35900余次，H指数=78 。
Gymnasium for Natural and Mathematical Sciences, Study course with extended focus
on Biology and Chemistry, Shumen, Bulgaria.
MSc in Biotechnology, Faculty of Biology, University of Sofia, Bulgaria.
PhD in Biochemistry, Department of Clinical Research, University of Bern,
Switzerland.
Postdoctoral fellowship at the Department of Clinical Research, University of Bern,
Switzerland.
Postdoctoral fellowship at the Institute of Pathology, Division of Immunopathology,
Inselspital, Bern, Switzerland.
Postdoctoral fellowship at the Department of Pharmacognosy, Faculty of Life Sciences,
University of Vienna, Austria.
Habilitation in Pharmaceutical Biology at the Department of Pharmacognosy,
University of Vienna, Austria.
分子医学
数字健康
开放式创新
生物技术
天然产物
科学传播
分子药理学
Atanasov AG, Zotchev SB, Dirsch VM; International Natural Product Sciences Taskforce, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021 Mar;20(3):200-216. doi: 10.1038/s41573-020-00114-z.
Yeung AWK, Kletecka-Pulker M, Eibensteiner F, Plunger P, Völkl-Kernstock S, Willschke H, Atanasov AG. Implications of Twitter in Health-Related Research: A Landscape Analysis of the Scientific Literature. Front Public Health. 2021 Jul 9;9:654481. doi: 10.3389/fpubh.2021.654481.
Wang D, Yang Y, Lei Y, Tzvetkov NT, Liu X, Yeung AWK, Xu S, Atanasov AG. Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products.Pharmacol Rev. 2019 Oct;71(4):596-670. doi: 10.1124/pr.118.017178.
Yeung AWK, Tzvetkov NT, El-Tawil OS, Bungǎu SG, Abdel-Daim MM, Atanasov AG. Antioxidants: Scientific Literature Landscape Analysis. Oxid Med Cell Longev. 2019 Jan 8;2019:8278454. doi: 10.1155/2019/8278454.
Wang L, Eftekhari P, Schachner D, Ignatova ID, Palme V, Schilcher N, Ladurner A, Heiss EH, Stangl H, Dirsch VM, Atanasov AG. Novel interactomics approach identifies ABCA1 as direct target of evodiamine, which increases macrophage cholesterol efflux. Sci Rep. 2018 Jul 23;8(1):11061. doi: 10.1038/s41598-018-29281-1.
Belwal T, Devkota HP, Hassan HA, Ahluwalia S, Ramadan MF, Mocan A, Atanasov AG. Phytopharmacology of Acerola (Malpighia spp.) and its potential as functional food.Trends Food Sci Technol, Volume 74, 2018, Pages 99-106, ISSN 0924-2244,https://doi.org/10.1016/j.tifs.2018.01.014.
Wang D, Tosevska A, Heiß EH, Ladurner A, Mölzer C, Wallner M, Bulmer A, Wagner KH, Dirsch VM, Atanasov AG. Bilirubin Decreases Macrophage Cholesterol Efflux and ATP-Binding Cassette Transporter A1 Protein Expression. J Am Heart Assoc. 2017 Apr 28;6(5). pii: e005520. doi: 10.1161/JAHA.117.005520.
Pferschy-Wenzig EM, Pferschy U, Wang D, Mocan A, Atanasov AG. Does a Graphical Abstract Bring More Visibility to Your Paper? Molecules. 2016 Sep 18;21(9). Atanasov AG, Wang JN, Gu SP, Bu J, Kramer MP, Baumgartner L, Fakhrudin N, Ladurner A,
Malainer C, Vuorinen A, Noha SM, Schwaiger S, Rollinger JM, Schuster D, Stuppner H, Dirsch VM, Heiss EH (2013). Honokiol: a non-adipogenic PPARgamma agonist from nature. Biochim Biophys Acta, 1830(10):4813-9.
Atanasov AG, Ignatova ID, Nashev LG, Dick B, Ferrari P, Frey FJ, Odermatt A (2007). Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess. J Am Soc Nephrol 18:1262-1270.
